Journal of Clinical Toxicology
Open Access

Department of Medical Oncology, Universitary Ramón y Cajal Hospital, Madrid, Spain

Publications

• Review Article   
  Impact of Covid-19 in Cancer Patients Treated with Immunotherapy: A Review
  Author(s): Cristina Saavedra*, Jorge Esteban, Lucía Sanz and Ainara Soria
  
  COVID-19 pandemic has been a devastating disease worldwide. Although an important number of young healthy people have been affected, elderly, comorbid and immunosuppressed patients have been especially compromised. Cancer patients usually share several of these features, being considered high risk population. Limited reliable information about cancer patients and COVID-19 are available, especially concerning to the risk that oncological therapies could involve. Immunotherapy is a novel therapy extensively used in oncology. Even though it is not a myelosuppressive treatment, its safety use in this context is unknown. Immunotherapy boosts immune system, mainly cytotoxic T cell response. This suggests that could have a favourable role in viral elimination. However, concerns about a detrimental influence have been discuss in oncological community. Most severe COVID-19 patients .. View More»
  DOI: 10.35248/2161-0495.20.10.449

  Abstract HTML PDF